Common Documentation Gaps That Delay Medical Device Regulatory Submissions

At MedLaunch, we see a common pattern behind many delayed regulatory submissions. The issue is often not the product concept or the test plan. It is the documentation. Strong documentation supports faster review because it gives regulators a clear, consistent record of how your device was designed, tested, and controlled. It also shows that your team has followed a disciplined process aligned with ISO 13485 and FDA 21 CFR Part 820.

Four documentation gaps cause the most trouble:

• Incomplete Design History Files and technical documentation
• Missing risk management linkages across development records
• Inconsistent verification and validation evidence
• Poorly structured submission-ready packages

Incomplete Design History Files and Technical Documentation

A Design History File, or DHF, should tell the full story of product development. Under FDA 21 CFR Part 820, the DHF must show that the design was developed in line with the approved design plan and applicable requirements. When records are missing, that story breaks apart.

Common gaps include absent design reviews, outdated specifications, missing design inputs and outputs, and weak traceability between development stages. Technical documentation can also fall short when teams fail to update drawings, labeling, software records, or usability files.

These omissions slow submissions because reviewers must stop and ask basic questions. What changed? Who approved it? Where is the supporting record? To avoid this, build documentation reviews into each development phase, not only at the end.

Missing Risk Management Linkages

Risk management should not sit in a separate file that no one connects to daily development work. ISO 14971 calls for risk management throughout the product lifecycle, and both ISO 13485 and Part 820 expect those activities to connect with design and quality records.

A common gap appears when hazards are identified in a risk file, but the related controls do not appear in design requirements, test protocols, labeling, or training materials. Another issue arises when teams update the device but fail to reassess related risks.

Reviewers look for clear linkages. They want to see that identified risks led to specific controls, and that those controls were verified and validated. A simple traceability matrix can help your team connect hazards, mitigations, requirements, and evidence in one place.

Inconsistent Verification and Validation Evidence

Verification and validation records must align with device requirements, risk controls, and intended use. When they do not, delays follow quickly.

We often find mismatched acceptance criteria, missing protocol approvals, unexplained deviations, and final reports that conflict with raw data or summary tables. In software and usability work, teams sometimes reference testing that was never fully documented or approved.

These issues create doubt about whether the device actually meets its requirements. Regulators may request clarification, more testing, or updated reports. The best way to prevent this is to standardize your V&V templates, review data for consistency before submission, and confirm that every claim has supporting evidence.

Poorly Structured Submission-Ready Packages

Even strong content can lose value if the submission package is disorganized. Reviewers need to find documents quickly, understand version history, and follow the logic of the submission without extra effort.

Common problems include inconsistent file naming, broken cross-references, missing document indexes, and mixed versions of the same record. These packaging issues create friction and can make a well-developed device appear poorly controlled.

A submission-ready package should be complete, clearly labeled, and easy to review. Use a standard folder structure, a master index, and final quality checks before release. Good organization saves time for both your team and the reviewer.

Contact MedLaunch for Help

Documentation gaps rarely fix themselves at the submission stage. They start earlier, during design, risk management, testing, and document control. A focused internal audit can help you spot weak points before they delay review. If your team needs support, MedLaunch can help you assess your current documentation practices and build a cleaner path to submission.